Table 2.
Controls | TAP-Cath | TAP-LB | p | |
---|---|---|---|---|
No. | 40 | 48 | 40 | |
Clinical variable | ||||
Chemotherapy | 0.8964 | |||
No | 33 | 38 | 33 | |
Yes | 7 | 10 | 7 | |
Radiotherapy | 0.1129 | |||
No | 35 | 34 | 28 | |
Yes | 5 | 14 | 12 | |
Surgical variables | ||||
Laterality | 0.1372 | |||
Unilateral | 26 | 30 | 18 | |
Bilateral | 14 | 18 | 22 | |
Timing | 0.0111 | |||
Immediate | 40 | 41 | 33 | |
Delayed | 0 | 7 | 7 | |
Type of abdominal flap | 0.2293 | |||
Total no. | 54 | 66 | 62 | |
MSI/II (TRAM) | 1 | 3 | 5 | |
MSIII (DIEP) | 53 | 62 | 55 | |
MSIY (SIEA) | 0 | 1 | 2 | |
Abdominall mesh | 0.0250 | |||
No | 40 | 47 | 35 | |
Yes | 0 | 1 | 5 |
MS, muscle-sparing; TRAM, transverse abdominis myocutaneous; DIEP, deep inferior epigastric artery perforator; SIEA, superficial inferior epigastric artery; TAP-Cath, transversus abdominis plane–catheter; TAP-LB, transversus abdominis plane–liposomal bupivacaine.